γ‐Glutamyl Transferase and Long‐Term Survival in the SYNTAXES Trial: Is It Just the Liver?

γ‐Glutamyl Transferase and Long‐Term Survival in the SYNTAXES Trial: Is It Just the Liver?

Background Recently, machine learning algorithms have identified preprocedural γ‐glutamyl transferase (GGT) as a significant predictor of long‐term mortality after coronary revascularization in the SYNTAX (Synergy Between PCI [Percutaneous Coronary Intervention] With Taxus and Cardiac Surgery) trial...

Full description

Saved in:
Bibliographic Details
Main Authors: Kai Ninomiya, Patrick W. Serruys, Scot Garg, Shigetaka Kageyama, Nozomi Kotoku, Shinichiro Masuda, Pruthvi C. Revaiah, Neil O'leary, Arie Pieter Kappetein, Michael J. Mack, David R. Holmes, Piroze M. Davierwala, Friedrich W. Mohr, Daniel J. F. M. Thuijs, Yoshinobu Onuma
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
biological marker
γ‐glutamyl transferase
long‐term clinical outcomes
machine learning
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032276
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.032276

Similar Items